首页 > 市场调查报告书 > 医疗设备

子宫内避孕器市场规模、份额和成长分析（按类型、产品类型、年龄层、应用和地区划分）—产业预测（2026-2033 年）

市场调查报告书

商品编码

1898061

子宫内避孕器市场规模、份额和成长分析（按类型、产品类型、年龄层、应用和地区划分）—产业预测（2026-2033 年）

Intrauterine Contraceptive Devices Market Size, Share, and Growth Analysis, By Type (Hormonal Intrauterine Device, Copper Intrauterine Device), By Product Type (Mirena, Skyla), By Age Group, By End Use, By Region - Industry Forecast 2026-2033

出版日期: 2025年12月22日 | 出版商:

SkyQuest | 英文 195 Pages | 商品交期: 3-5个工作天内

价格

简介目录

全球子宫内避孕器 (IUD) 市场规模预计在 2024 年达到 46 亿美元，从 2025 年的 48.1 亿美元成长到 2033 年的 69 亿美元，在预测期（2026-2033 年）内复合年增长率为 4.6%。

受计划生育和生殖健康意识不断提高的推动，全球子宫内避孕器（IUD）市场正经历显着增长。子宫内避孕器以其高效性和便利性而着称，无需每日干预即可提供长期避孕保护。其价格合理且安全，吸引了不同年龄层的女性，加上政府和机构对孕产妇健康倡议的支持，共同推动了市场发展。无激素产品的需求不断增长，以及提升用户体验的技术创新，也促进了市场成长。儘管文化差异和对安全性的误解可能在某些地区阻碍子宫内避孕器的普及，但开发中国家医疗保健服务的普及正在创造新的机会。儘管面临成本和来自其他避孕方法的竞争等挑战，子宫内避孕器仍然是许多寻求可靠避孕方式的女性的首选。

全球子宫内避孕器市场按类型、产品类型、年龄层、最终用途和地区进行细分。依类型划分，子宫内避孕器分为含激素子宫内避孕器和含铜子宫内避孕器。依产品类型划分，子宫内避孕器分为曼月乐 (Mirena)、斯凯拉 (Skyra)、帕拉加德 (Paragard)、艾舒瑞 (Essure)、瑞沃塞特 (Revosert) 和其他产品。依年龄组别划分，子宫内避孕器分为 15-24 岁、25-34 岁、35-44 岁及 45 岁以上。依最终用途划分，子宫内避孕器分为医院、妇科诊所、社区健康中心和其他机构。按地区划分，子宫内避孕器分为北美、欧洲、亚太、拉丁美洲以及中东和非洲。

全球子宫内避孕器市场驱动因素

全球子宫内避孕器市场主要受长效可逆避孕方法（LARC）需求成长的驱动，尤其是子宫内避孕器（IUD）。由于其避孕效果高、维护简单且能提供长期避孕保护，越来越多的女性选择这些方法。子宫内避孕器的避孕有效率超过99%，有效期限为3至10年，是短期避孕方法的便利替代方案。此外，医疗专业人员也越来越多地推荐这些长效可逆避孕方法作为第一线选择，进一步促进了其普及。宣传这些节育器益处和可靠性的宣传活动不断增加，有助于提高其在不同人群和地区的接受度。

压制全球子宫内避孕器市场

由于文化和社会因素阻碍了子宫内避孕器的普及，全球市场面临严峻的挑战。儘管子宫内避孕器具有许多医疗益处，但由于人们对其安全性、对生育能力的影响以及放置过程中可能出现的不适感存在持续的误解，许多地区仍然不愿采用。避孕在不同文化中仍然是一个敏感话题，这使得女性难以获得子宫内避孕器等有效的避孕方法。此外，对严重副作用的担忧和宗教信仰的反对意见也进一步加剧了人们对子宫内避孕器的接受度。为了提高市场渗透率，进行有针对性的教育活动和社区宣传计画至关重要，这有助于提高人们对子宫内避孕器的认识，并促进犹豫不决的人群接受使用子宫内避孕器。

全球子宫内避孕器市场趋势

全球子宫内避孕器市场正经历着向非荷尔蒙避孕方式的显着转变，这主要得益于消费者对无荷尔蒙产品的偏好。随着人们对荷尔蒙避孕潜在副作用的认识不断提高，铜子宫内避孕器等产品在註重健康的女性中越来越受欢迎，她们寻求的是不会扰乱荷尔蒙平衡的长期解决方案。这一趋势也推动了人们对舒适便捷的非侵入性避孕方式的需求成长。因此，製造商正不断创新，以提升非荷尔蒙子宫内避孕器的吸引力和功能性，使其成为具有竞争力的替代方案，并正在重塑全球避孕市场的竞争格局。

前五大公司对比
主要企业的市场定位（2025 年）
主要市场参与者所采取的策略
近期市场趋势
公司市占率分析（2025 年）
主要企业公司简介
- 公司详情
- 产品系列分析
- 依业务板块进行公司股票分析
- 2023-2025年营收年比比较
主要企业简介
- 梯瓦製药工业股份有限公司（耶路撒冷）
- 拜耳（德国）
- EUROGINE（西班牙）
- CooperSurgical Inc.（美国）
- 辉瑞公司（美国）
- HLL Lifecare Limited（特里凡得琅）
- OCON Medical Ltd.（以色列）
- Prosan International BV（荷兰）
- Melbea Innovations（匈牙利）
- 艾尔建，默克公司（美国）
- DKT国际（美国）
- Medisafe Distribution Inc.（加拿大）
- Medicines360（美国）
- Pregna International Limited（印度）
- 埃格门国际（土耳其）

结论与建议

简介目录

Product Code: SQMIG35A3009

Global Intrauterine Contraceptive Devices Market size was valued at USD 4.6 Billion in 2024 and is poised to grow from USD 4.81 Billion in 2025 to USD 6.9 Billion by 2033, growing at a CAGR of 4.6% during the forecast period (2026-2033).

The global market for Intrauterine Contraceptive Devices (IUDs) is experiencing significant growth driven by heightened awareness of family planning and reproductive health. IUDs are recognized for their effectiveness and low maintenance, providing extended pregnancy protection without daily attention. Their affordability and safety profile appeal to a diverse female demographic, further fueled by governmental and organizational support for maternal health initiatives. The rising demand for hormone-free options has also propelled the market, complemented by technological advancements that enhance user experience. While cultural resistance and myths concerning safety can hinder adoption, particularly in specified regions, the increasing access to healthcare in developing countries presents new opportunities. Despite challenges such as cost and competition from other contraceptives, IUDs remain a preferred choice for many women seeking reliable birth control solutions.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Intrauterine Contraceptive Devices market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Intrauterine Contraceptive Devices Market Segments Analysis

The Global Intrauterine Contraceptive Devices Market is segmented by Type, Product Type, Age Group, End Use and region. Based on Type, the market is segmented into Hormonal Intrauterine Device and Copper Intrauterine Device. Based on Product Type, the market is segmented into Mirena, Skyla, Paragard, Essure, Levosert and Others. Based on Age Group, the market is segmented into 15-24 years, 25-34 years, 35-44 years and Above 44 years. Based on End Use, the market is segmented into Hospitals, Gynecology Clinics, Community Health Care Centers and Others. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Global Intrauterine Contraceptive Devices Market

The Global Intrauterine Contraceptive Devices market is significantly driven by the rising preference for long-acting reversible contraceptives, particularly intrauterine devices (IUDs). Women are increasingly choosing these options due to their high efficacy, minimal maintenance, and prolonged effectiveness in pregnancy prevention. With over 99% effectiveness and the ability to last between three to ten years, IUDs offer a convenient alternative to short-term contraceptives. Additionally, healthcare providers frequently recommend these long-acting reversible contraceptive methods as a primary option, further boosting their adoption. Enhanced awareness initiatives highlighting the advantages and reliability of these devices are fostering broader acceptance across diverse populations and regions.

Restraints in the Global Intrauterine Contraceptive Devices Market

The global market for intrauterine contraceptive devices faces significant challenges due to cultural and social factors that hinder their adoption. Despite their medical benefits, many regions remain hesitant to embrace IUDs, largely due to persistent misinformation regarding their safety, impact on fertility, and potential discomfort during insertion. In various cultures, contraception remains a sensitive topic, making it difficult for women to access effective birth control options like IUDs. Additionally, fears surrounding severe side effects and religious objections further complicate acceptance. To improve market penetration, targeted educational initiatives and community outreach programs are essential to raise awareness and enhance acceptance of IUDs among hesitant populations.

Market Trends of the Global Intrauterine Contraceptive Devices Market

The Global Intrauterine Contraceptive Devices market is experiencing a notable shift towards non-hormonal contraceptives, driven by an increasing consumer preference for hormone-free options. As awareness of potential side effects associated with hormonal birth control rises, products like the Copper IUD are gaining traction among health-conscious women seeking long-term solutions that do not disrupt hormonal balance. This trend underscores a growing appetite for non-invasive contraceptive methods that offer comfort and user-friendly designs. Consequently, manufacturers are innovating to enhance the appeal and functionality of non-hormonal IUDs, positioning them as competitive alternatives in the global contraceptive landscape.

Introduction

Objectives of the Study
Scope of the Report
Definitions

Research Methodology

Information Procurement
Secondary & Primary Data Methods
Market Size Estimation
Market Assumptions & Limitations

Executive Summary

Global Market Outlook
Supply & Demand Trend Analysis
Segmental Opportunity Analysis

Market Dynamics & Outlook

Market Overview
Market Size
Market Dynamics
- Drivers & Opportunities
- Restraints & Challenges
Porters Analysis
- Competitive rivalry
- Threat of substitute
- Bargaining power of buyers
- Threat of new entrants
- Bargaining power of suppliers

Key Market Insights

Key Success Factors
Degree of Competition
Top Investment Pockets
Market Ecosystem
Market Attractiveness Index, 2025
PESTEL Analysis
Macro-Economic Indicators
Value Chain Analysis
Pricing Analysis
Regulatory Landscape
Case Studies
Technology Analysis
Customer & Buying Criteria Analysis

Global Intrauterine Contraceptive Devices Market Size by Type & CAGR (2026-2033)

Market Overview
Hormonal Intrauterine Device
Copper Intrauterine Device

Global Intrauterine Contraceptive Devices Market Size by Product Type & CAGR (2026-2033)

Market Overview
Mirena
Skyla
Paragard
Essure
Levosert
Others

Global Intrauterine Contraceptive Devices Market Size by Age Group & CAGR (2026-2033)

Market Overview
15-24 years
25-34 years
35-44 years
Above 44 years

Global Intrauterine Contraceptive Devices Market Size by End Use Industry & CAGR (2026-2033)

Market Overview
Hospitals
Gynecology Clinics
Community Health Care Centers
Others

Global Intrauterine Contraceptive Devices Market Size & CAGR (2026-2033)

North America (Type, Product Type, Age Group, End Use Industry)
- US
- Canada
Europe (Type, Product Type, Age Group, End Use Industry)
- Germany
- Spain
- France
- UK
- Italy
- Rest of Europe
Asia Pacific (Type, Product Type, Age Group, End Use Industry)
- China
- India
- Japan
- South Korea
- Rest of Asia-Pacific
Latin America (Type, Product Type, Age Group, End Use Industry)
- Brazil
- Rest of Latin America
Middle East & Africa (Type, Product Type, Age Group, End Use Industry)
- GCC Countries
- South Africa
- Rest of Middle East & Africa

Competitive Intelligence

Top 5 Player Comparison
Market Positioning of Key Players, 2025
Strategies Adopted by Key Market Players
Recent Developments in the Market
Company Market Share Analysis, 2025
Company Profiles of All Key Players
- Company Details
- Product Portfolio Analysis
- Company's Segmental Share Analysis
- Revenue Y-O-Y Comparison (2023-2025)

Key Company Profiles

Teva Pharmaceutical Industries Ltd. (Jerusalem)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Bayer (Germany)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
EUROGINE (Spain)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
CooperSurgical Inc. (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Pfizer Inc. (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
HLL Lifecare Limited (Thiruvananthapuram)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
OCON Medical Ltd. (Israel)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Prosan International BV (Netherlands)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Melbea Innovations (Hungary)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Allergan, Merck & Co., Inc. (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
DKT International (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Medisafe Distribution Inc. (Canada)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Medicines360 (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Pregna International Limited (India)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Egemen International (Turkey)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments